Wasatch Micro Cap Fund Q4 2025 Performance Review
Source: SeekingAlpha
2026-02-04 08:35:00 ET
...
Read the full article on Seeking Alpha
For further details see:
Wasatch Micro Cap Fund Q4 2025 Performance Review
Castle Biosciences Inc.
NASDAQ: CSTL
CSTL Trading
4.38% G/L:
$27.07 Last:
80,223 Volume:
$26.95 Open:
CSTL Latest News
March 09, 2026 07:00:00 am
DecisionDx®-Melanoma's i31-SLNB: Report from the Largest Prospective Multicenter Study to Date Confirms 2.6% Nodal Positivity in Patients Predicted to Have Less Than 5% Risk
March 04, 2026 04:30:00 pm
Castle Biosciences to Present Data at SSO 2026 on DecisionDx®-Melanoma's i31-SLNB, Identifying T1b-T2a Melanoma Patients Who May Safely Avoid SLNB
March 03, 2026 04:30:00 pm
Castle Biosciences Announces Grand Opening of New Corporate Headquarters in Friendswood, Texas
CSTL Stock Data
$948,047,644
27,291,396
0.3%
60
N/A
Medical Diagnostics & Screening
Healthcare
US
Friendswood
